Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients
- PMID: 7059938
- DOI: 10.1002/1097-0142(19820315)49:6<1131::aid-cncr2820490611>3.0.co;2-t
Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients
Abstract
For 1704 patients with large bowel cancer compiled by the Armed Forces Central Medical Registry, selected prognostic factors were related to five-year or longer survival. The majority of late deaths (those occurring after five years) resulted from cancer in the descending colon, sigmoid colon or rectum rather than from cancer in the right or transverse colon. For example, among all patients with cancer of the rectum, 15.4% of those with Dukes' B tumors and 10.9% of those with Dukes' C tumors died of rectal cancer between five and ten years after diagnosis. When late survival rates were compared, patients with right and transverse colon cancer (8 deaths/93 at risk) fared significantly better than those with left colon and rectal cancer (33 deaths/171 at risk; P = 0.01). Among patients with left-sided colon and rectal carcinoma, a further significant difference in late survival was found when stage of disease was considered: patients with Dukes' A cancers (3 deaths/47 at risk after five years) fared better than those with Dukes' C cancers (21 deaths/74 at risk) (P = 0.002). For Dukes' B and C stages of disease, patients with left colon and rectal cancer fared worse than those with right and transverse colon lesions after 60 months. Of all patients who died of large bowel cancer after five years, 69% had a recurrence of cancer by 60 months, and most late recurrences were located in the descending and sigmoid colon and in the rectum. These results show differences in survival after five years with respect to both site of cancer in the colon and stage of initial disease. Our findings indicate that many left-sided large bowel cancers have a slowly progressive natural history.
Similar articles
-
Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study.Dis Colon Rectum. 1990 Nov;33(11):938-46. doi: 10.1007/BF02139103. Dis Colon Rectum. 1990. PMID: 2226081
-
Intramural spread of colon carcinoma. A pathologic study.Am J Surg. 1983 Dec;146(6):697-9. doi: 10.1016/0002-9610(83)90320-3. Am J Surg. 1983. PMID: 6650750
-
Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum.Surg Gynecol Obstet. 1977 May;144(5):677-81. Surg Gynecol Obstet. 1977. PMID: 850850
-
[Did the stage of diagnosis and the surgical management of colonic cancers change over the last ten years? Apropos of 303 patients].Ann Chir. 1994;48(7):591-5. Ann Chir. 1994. PMID: 7864533 Review. French.
-
Adenocarcinoma of the colon and rectum: a report on 624 cases.Neth J Surg. 1988 Oct;40(5):121-6. Neth J Surg. 1988. PMID: 3068581 Review.
Cited by
-
Beppu's Nomogram Score Is an Independent Prognostic Factor for Colorectal Liver Metastasis Receiving Perioperative Chemotherapy and/or Targeted Therapy.In Vivo. 2019 Jul-Aug;33(4):1301-1306. doi: 10.21873/invivo.11603. In Vivo. 2019. PMID: 31280222 Free PMC article.
-
High prevalence of isolated tumour cells in regional lymph nodes from pN0 colorectal cancer.J Clin Pathol. 2006 Aug;59(8):870-4. doi: 10.1136/jcp.2005.036350. Epub 2006 Apr 7. J Clin Pathol. 2006. PMID: 16603645 Free PMC article.
-
Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells.Jpn J Cancer Res. 1998 Feb;89(2):206-13. doi: 10.1111/j.1349-7006.1998.tb00550.x. Jpn J Cancer Res. 1998. PMID: 9548449 Free PMC article.
-
Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.Clin Exp Metastasis. 2004;21(4):321-9. doi: 10.1023/b:clin.0000046133.35133.cc. Clin Exp Metastasis. 2004. PMID: 15554388
-
The expression and significance of feces cyclooxygensae-2 mRNA in colorectal cancer and colorectal adenomas.Saudi J Gastroenterol. 2017 Jan-Feb;23(1):28-33. doi: 10.4103/1319-3767.199112. Saudi J Gastroenterol. 2017. PMID: 28139497 Free PMC article.